• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于证据的方法来评估酰胺质子转移加权磁共振成像在胶质瘤特征描述中的准确性。

An evidence-based approach to evaluate the accuracy of amide proton transfer-weighted MRI in characterization of gliomas.

作者信息

Zhao Jiaying, Huang Songtao, Xie Huan, Li Wenfei

机构信息

Department of Rheumatology and Immunology.

Department of Radiology, Guang'an People's Hospital, Sichuan.

出版信息

Medicine (Baltimore). 2019 Mar;98(10):e14768. doi: 10.1097/MD.0000000000014768.

DOI:10.1097/MD.0000000000014768
PMID:30855481
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6417527/
Abstract

BACKGROUD

To perform a meta-analysis to evaluate the diagnostic accuracy of the amide proton transfer (APT) technique in differentiating high-grade gliomas (HGGs) from low grade gliomas (LGGs).

METHODS

Medical literature databases were searched for studies that evaluated the diagnostic accuracy of APT in patients suspected of brain tumor who underwent APT MRI and surgery. Only English language studies and published before September 2018 were considered to be included in this project. Homogeneity was assessed by the inconsistency index. Mean difference (MD) at 95% confidence interval (CI) of all parameters derived from APT was calculated. Publication bias was explored by Egger's funnel plot.

RESULTS

Six eligible studies were included in the meta-analysis, comprising 144 HGGs and 122 LGGs. The APT-related parameter signal intensity (SI) was significantly higher in the HGG than the LGG (WMD = 0.86 (0.61-1.1), P < .0001); A significant difference was also found between grade II and grade III (WMD = 0.6 (0.4-0.8), P < .0001), and between grade II and grade IV (WMD = 1.07 (0.65-1.49), P < .0001).

CONCLUSIONS

APT imaging may be a useful imaging biomarker for discriminating between LGGs and HGGs. However, large randomized control trials (RCT) were necessary to evaluate its clinical value.

摘要

背景

进行一项荟萃分析,以评估酰胺质子转移(APT)技术在鉴别高级别胶质瘤(HGG)与低级别胶质瘤(LGG)中的诊断准确性。

方法

检索医学文献数据库,查找评估接受APT磁共振成像(MRI)和手术的疑似脑肿瘤患者中APT诊断准确性的研究。仅纳入2018年9月之前发表的英文研究。通过不一致指数评估同质性。计算来自APT的所有参数在95%置信区间(CI)的平均差异(MD)。通过Egger漏斗图探讨发表偏倚。

结果

六项符合条件的研究纳入荟萃分析,包括144例HGG和122例LGG。HGG中与APT相关的参数信号强度(SI)显著高于LGG(加权平均差[WMD] = 0.86[0.61 - 1.1],P <.0001);在II级和III级之间(WMD = 0.6[0.4 - 0.8],P <.0001)以及II级和IV级之间(WMD = 1.07[0.65 - 1.49],P <.0001)也发现了显著差异。

结论

APT成像可能是鉴别LGG和HGG的一种有用的成像生物标志物。然而,需要大型随机对照试验(RCT)来评估其临床价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/795e/6417527/25a408827ca4/medi-98-e14768-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/795e/6417527/b99c57974715/medi-98-e14768-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/795e/6417527/f7b0d20e7c99/medi-98-e14768-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/795e/6417527/cb6781c67a08/medi-98-e14768-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/795e/6417527/936dec010668/medi-98-e14768-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/795e/6417527/25a408827ca4/medi-98-e14768-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/795e/6417527/b99c57974715/medi-98-e14768-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/795e/6417527/f7b0d20e7c99/medi-98-e14768-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/795e/6417527/cb6781c67a08/medi-98-e14768-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/795e/6417527/936dec010668/medi-98-e14768-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/795e/6417527/25a408827ca4/medi-98-e14768-g006.jpg

相似文献

1
An evidence-based approach to evaluate the accuracy of amide proton transfer-weighted MRI in characterization of gliomas.一种基于证据的方法来评估酰胺质子转移加权磁共振成像在胶质瘤特征描述中的准确性。
Medicine (Baltimore). 2019 Mar;98(10):e14768. doi: 10.1097/MD.0000000000014768.
2
Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.通过酰胺质子转移磁共振成像对无强化的弥漫性胶质瘤进行分级:与扩散加权成像和灌注加权成像的比较
Eur Radiol. 2017 Feb;27(2):578-588. doi: 10.1007/s00330-016-4328-0. Epub 2016 Mar 22.
3
Grading of Glioma: combined diagnostic value of amide proton transfer weighted, arterial spin labeling and diffusion weighted magnetic resonance imaging.胶质瘤分级:酰胺质子转移加权成像、动脉自旋标记和扩散加权磁共振成像的联合诊断价值
BMC Med Imaging. 2020 May 14;20(1):50. doi: 10.1186/s12880-020-00450-x.
4
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
5
Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.使用7T低功率稳态脉冲化学交换饱和转移(CEST)成像技术对胶质瘤患者进行全脑酰胺质子转移(APT)和核Overhauser增强(NOE)成像。
J Magn Reson Imaging. 2016 Jul;44(1):41-50. doi: 10.1002/jmri.25108. Epub 2015 Dec 10.
6
The role of APT imaging in gliomas grading: A systematic review and meta-analysis.APT 成像在胶质瘤分级中的作用:系统评价和荟萃分析。
Eur J Radiol. 2020 Dec;133:109353. doi: 10.1016/j.ejrad.2020.109353. Epub 2020 Oct 16.
7
Amide proton transfer-weighted MRI in distinguishing high- and low-grade gliomas: a systematic review and meta-analysis.酰胺质子转移加权磁共振成像在鉴别高级别和低级别胶质瘤中的应用:一项系统综述和荟萃分析。
Neuroradiology. 2019 May;61(5):525-534. doi: 10.1007/s00234-018-02152-2. Epub 2019 Jan 21.
8
Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume.酰胺质子转移成像鉴别低级别与高级别胶质瘤:对表观扩散系数和相对脑血容量的附加价值
Eur Radiol. 2017 Aug;27(8):3181-3189. doi: 10.1007/s00330-017-4732-0. Epub 2017 Jan 23.
9
An evidence-based approach to assess the accuracy of intravoxel incoherent motion imaging for the grading of brain tumors.一种基于证据的方法来评估体素内不相干运动成像在脑肿瘤分级中的准确性。
Medicine (Baltimore). 2018 Nov;97(45):e13217. doi: 10.1097/MD.0000000000013217.
10
Diagnostic accuracy of dynamic contrast-enhanced perfusion MRI in stratifying gliomas: A systematic review and meta-analysis.动态对比增强磁共振灌注成像在胶质瘤分级中的诊断准确性:系统评价和荟萃分析。
Cancer Med. 2019 Sep;8(12):5564-5573. doi: 10.1002/cam4.2369. Epub 2019 Aug 7.

引用本文的文献

1
Image quality assessment and feasibility of three-dimensional amide proton transfer-weighted imaging for hepatocellular carcinoma.肝细胞癌三维酰胺质子转移加权成像的图像质量评估及可行性
Quant Imaging Med Surg. 2024 Feb 1;14(2):1778-1790. doi: 10.21037/qims-23-767. Epub 2024 Jan 23.
2
Three-Dimensional Amide Proton Transfer-Weighted Imaging for Differentiating between Glioblastoma, IDH-Wildtype and Primary Central Nervous System Lymphoma.三维酰胺质子转移加权成像用于鉴别胶质母细胞瘤、异柠檬酸脱氢酶野生型和原发性中枢神经系统淋巴瘤
Cancers (Basel). 2023 Feb 2;15(3):952. doi: 10.3390/cancers15030952.

本文引用的文献

1
Chemical exchange saturation transfer (CEST) signal intensity at 7T MRI of WHO IV° gliomas is dependent on the anatomic location.7T MRI 下 WHO IV 级脑胶质瘤的化学交换饱和传递(CEST)信号强度与解剖位置有关。
J Magn Reson Imaging. 2019 Mar;49(3):777-785. doi: 10.1002/jmri.26215. Epub 2018 Aug 22.
2
Amid proton transfer (APT) and magnetization transfer (MT) MRI contrasts provide complimentary assessment of brain tumors similarly to proton magnetic resonance spectroscopy imaging (MRSI).在质子转移 (APT) 和磁化转移 (MT) MRI 对比中,质子磁共振波谱成像 (MRSI) 同样为脑肿瘤提供了互补性评估。
Eur Radiol. 2019 Mar;29(3):1203-1210. doi: 10.1007/s00330-018-5615-8. Epub 2018 Aug 13.
3
Prognostic role of survivin in patients with glioma.
生存素在胶质瘤患者中的预后作用。
Medicine (Baltimore). 2018 Apr;97(17):e0571. doi: 10.1097/MD.0000000000010571.
4
Diagnostic performance of apparent diffusion coefficient parameters for glioma grading.表观扩散系数参数在胶质瘤分级中的诊断性能。
J Neurooncol. 2018 Aug;139(1):61-68. doi: 10.1007/s11060-018-2841-5. Epub 2018 Mar 24.
5
Radiomics strategy for glioma grading using texture features from multiparametric MRI.基于多参数 MRI 纹理特征的脑胶质瘤分级放射组学策略。
J Magn Reson Imaging. 2018 Dec;48(6):1518-1528. doi: 10.1002/jmri.26010. Epub 2018 Mar 23.
6
Glioma grading by dynamic susceptibility contrast perfusion and C-methionine positron emission tomography using different regions of interest.应用不同感兴趣区的动态磁敏感对比灌注和 C-蛋氨酸正电子发射断层成像对胶质瘤进行分级。
Neuroradiology. 2018 Apr;60(4):381-389. doi: 10.1007/s00234-018-1993-5. Epub 2018 Feb 20.
7
Addition of Amide Proton Transfer Imaging to FDG-PET/CT Improves Diagnostic Accuracy in Glioma Grading: A Preliminary Study Using the Continuous Net Reclassification Analysis.酰胺质子转移成像与 FDG-PET/CT 联合应用提高胶质瘤分级诊断准确性:连续净重新分类分析的初步研究。
AJNR Am J Neuroradiol. 2018 Feb;39(2):265-272. doi: 10.3174/ajnr.A5503. Epub 2018 Jan 4.
8
Differentiating the histologic grades of gliomas preoperatively using amide proton transfer-weighted (APTW) and intravoxel incoherent motion MRI.使用酰胺质子转移加权(APTW)和体素内不相干运动MRI术前区分胶质瘤的组织学分级。
NMR Biomed. 2018 Jan;31(1). doi: 10.1002/nbm.3850. Epub 2017 Nov 3.
9
Amide Proton Transfer Imaging Allows Detection of Glioma Grades and Tumor Proliferation: Comparison with Ki-67 Expression and Proton MR Spectroscopy Imaging.酰胺质子转移成像是一种可以检测胶质瘤分级和肿瘤增殖的方法:与 Ki-67 表达和质子磁共振波谱成像的比较。
AJNR Am J Neuroradiol. 2017 Sep;38(9):1702-1709. doi: 10.3174/ajnr.A5301. Epub 2017 Jul 20.
10
Amide proton transfer imaging for differentiation of benign and atypical meningiomas.酰胺质子转移成像在鉴别良、非典型脑膜瘤中的应用。
Eur Radiol. 2018 Jan;28(1):331-339. doi: 10.1007/s00330-017-4962-1. Epub 2017 Jul 7.